Autocrine TNF is critical for the survival of human dendritic cells by regulating BAK, BCL-2, and FLIP L

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 4810-4818

  Lehner, Manfred ^a   Kellert, Beate ^b   Proff, Julia ^a   Schmid, Martina A ^a   Diessenbacher, Philip ^b   Ensser, Armin ^c   Dörrie, Jan ^a   Schaft, Niels ^a   Leverkus, Martin ^b   Kämpgen, Eckhart ^a   Holter, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P70; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN BAK; PROTEIN BCL 2; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN SECRETION; UBIQUITINATION;

APOPTOSIS REGULATORY PROTEINS; AUTOCRINE COMMUNICATION; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL COUNT; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861123852     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101610     Document Type: Article

References (59)

1. Nopora, A., and T. Brocker. 2002. Bcl-2 controls dendritic cell longevity in vivo. J. Immunol. 169: 3006-3014. (Pubitemid 35013143)
2. Hou, W. S., and L. Van Parijs. 2004. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat. Immunol. 5: 583-589. (Pubitemid 38811882)
3. Hon, H., E. B. Rucker, III, L. Hennighausen, and J. Jacob. 2004. bcl-xL is critical for dendritic cell survival in vivo. J. Immunol. 173: 4425-4432. (Pubitemid 39280672)
4. Chen, M., L. Huang, and J. Wang. 2007. Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood 109: 4360-4367. (Pubitemid 46743404)
5. Zanoni, I., R. Ostuni, G. Capuano, M. Collini, M. Caccia, A. E. Ronchi, M. Rocchetti, F. Mingozzi, M. Foti, G. Chirico, et al. 2009. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 460: 264-268.
6. Chen, M., L. Huang, Z. Shabier, and J. Wang. 2007. Regulation of the lifespan in dendritic cell subsets. Mol. Immunol. 44: 2558-2565. (Pubitemid 46240333)
7. Kim, T. W., C. F. Hung, M. Ling, J. Juang, L. He, J. M. Hardwick, S. Kumar, and T. C. Wu. 2003. Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. J. Clin. Invest. 112: 109-117. (Pubitemid 38056382)
8. Kim, T. W., J. H. Lee, L. He, D. A. Boyd, J. M. Hardwick, C. F. Hung, and T. C. Wu. 2005. Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency. Cancer Res. 65: 309-316. (Pubitemid 40070823)
9. Wang, T., Q. Jiang, C. Chan, K. S. Gorski, E. McCadden, D. Kardian, D. Pardoll, and K. A. Whartenby. 2009. Inhibition of activation-induced death of dendritic cells and enhancement of vaccine efficacy via blockade of MINOR. Blood 113: 2906-2913.
10. Hasan, U. A., C. Caux, I. Perrot, A. C. Doffin, C. Menetrier-Caux, G. Trinchieri, M. Tommasino, and J. Vlach. 2007. Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs. Proc. Natl. Acad. Sci. USA 104: 8047-8052. (Pubitemid 47185873)
11. Yen, J. H., and D. Ganea. 2009. Interferon beta induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation. Blood 114: 1344-1354.
12. Salaun, B., P. Romero, and S. Lebecque. 2007. Toll-like receptors' two-edged sword: when immunity meets apoptosis. Eur. J. Immunol. 37: 3311-3318.
13. Hausmann, S., J. B. Marq, C. Tapparel, D. Kolakofsky, and D. Garcin. 2008. RIG-I and dsRNA-induced IFNbeta activation. PLoS ONE 3: e3965.
14. Weber, A., Z. Kirejczyk, R. Besch, S. Potthoff, M. Leverkus, and G. Häcker. 2010. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death Differ. 17: 942-951.
15. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458. (Pubitemid 40835033)
16. Kriehuber, E., W. Bauer, A. S. Charbonnier, D. Winter, S. Amatschek, D. Tamandl, N. Schweifer, G. Stingl, and D. Maurer. 2005. Balance between NF-kappaB and JNK/AP-1 activity controls dendritic cell life and death. Blood 106: 175-183. (Pubitemid 40967190)
17. Micheau, O., and J. Tschopp. 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190. (Pubitemid 36936912)
18. Bianchi, K., and P. Meier. 2009. A tangled web of ubiquitin chains: breaking news in TNF-R1 signaling. Mol. Cell 36: 736-742.
19. Wertz, I. E., K. M. O'Rourke, H. Zhou, M. Eby, L. Aravind, S. Seshagiri, P. Wu, C. Wiesmann, R. Baker, D. L. Boone, et al. 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699. (Pubitemid 39061687)
20. Haas, T. L., C. H. Emmerich, B. Gerlach, A. C. Schmukle, S. M. Cordier, E. Rieser, R. Feltham, J. Vince, U. Warnken, T. Wenger, et al. 2009. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36: 831-844.
21. Rahighi, S., F. Ikeda, M. Kawasaki, M. Akutsu, N. Suzuki, R. Kato, T. Kensche, T. Uejima, S. Bloor, D. Komander, et al. 2009. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136: 1098-1109.
22. Diessenbacher, P., M. Hupe, M. R. Sprick, A. Kerstan, P. Geserick, T. L. Haas, T. Wachter, M. Neumann, H. Walczak, J. Silke, and M. Leverkus. 2008. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2. J. Invest. Dermatol. 128: 1134-1147. (Pubitemid 351543191)
23. Lehner, M., P. Morhart, A. Stilper, D. Petermann, P. Weller, D. Stachel, and W. Holter. 2007. Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptors. J. Immunother. 30: 312-322. (Pubitemid 46586647)
24. Schaft, N., J. Dörrie, P. Thumann, V. E. Beck, I. Müller, E. S. Schultz, E. Kämpgen, D. Dieckmann, and G. Schuler. 2005. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation. J. Immunol. 174: 3087-3097. (Pubitemid 40279731)
25. Griffiths, G. J., L. Dubrez, C. P. Morgan, N. A. Jones, J. Whitehouse, B. M. Corfe, C. Dive, and J. A. Hickman. 1999. Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J. Cell Biol. 144: 903-914. (Pubitemid 29238967)
26. Leverkus, M., A. D. McLellan, M. Heldmann, A. O. Eggert, E. B. Bröcker, N. Koch, and E. Kämpgen. 2003. MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways. Int. Immunol. 15: 993-1006. (Pubitemid 36987297)
27. Geserick, P., M. Hupe, M. Moulin, W. W. Wong, M. Feoktistova, B. Kellert, H. Gollnick, J. Silke, and M. Leverkus. 2009. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J. Cell Biol. 187: 1037-1054.
28. Lundberg, A. M., S. K. Drexler, C. Monaco, L. M. Williams, S. M. Sacre, M. Feldmann, and B. M. Foxwell. 2007. Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood 110: 3245-3252. (Pubitemid 350106317)
29. Björck, P., J. Banchereau, and L. Flores-Romo. 1997. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int. Immunol. 9: 365-372. (Pubitemid 27113261)
30. Koppi, T. A., T. Tough-Bement, D. M. Lewinsohn, D. H. Lynch, and M. R. Alderson. 1997. CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells. Eur. J. Immunol. 27: 3161-3165. (Pubitemid 28018010)
31. Leverkus, M., H. Walczak, A. McLellan, H. W. Fries, G. Terbeck, E. B. Bröcker, and E. Kämpgen. 2000. Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis. Blood 96: 2628-2631.
32. Hasebe, H., K. Sato, H. Yanagie, Y. Takeda, Y. Nonaka, T. A. Takahashi, M. Eriguchi, and H. Nagawa. 2002. Bcl-2, Bcl-xL and c-FLIP(L) potentially regulate the susceptibility of human peripheral blood monocyte-derived dendritic cells to cell death at different developmental stages. Biomed. Pharmacother. 56: 144-151. (Pubitemid 34442476)
33. Napolitani, G., A. Rinaldi, F. Bertoni, F. Sallusto, and A. Lanzavecchia. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6: 769-776. (Pubitemid 43090462)
34. Lehner, M., P. Morhart, A. Stilper, and W. Holter. 2005. Functional characterization of monocyte-derived dendritic cells generated under serumfree culture conditions. Immunol. Lett. 99: 209-216. (Pubitemid 40966036)
35. Ludewig, B., D. Graf, H. R. Gelderblom, Y. Becker, R. A. Kroczek, and G. Pauli. 1995. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. Eur. J. Immunol. 25: 1943-1950.
36. Chen, B., Y. Shi, J. D. Smith, D. Choi, J. D. Geiger, and J. J. Mulé. 1998. The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro. Blood 91: 4652-4661. (Pubitemid 28270314)
37. Um, H. D., Y. H. Cho, D. K. Kim, J. R. Shin, Y. J. Lee, K. S. Choi, J. M. Kang, and M. G. Lee. 2004. TNF-alpha suppresses dendritic cell death and the production of reactive oxygen intermediates induced by plasma withdrawal. Exp. Dermatol. 13: 282-288.
38. Lundqvist, A., T. Nagata, R. Kiessling, and P. Pisa. 2002. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L). Cancer Immunol. Immunother. 51: 139-144. (Pubitemid 34298109)
39. Lutz, M. B., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23: 445-449. (Pubitemid 35015188)
40. Voigtländer, C., S. Rössner, E. Cierpka, G. Theiner, C. Wiethe, M. Menges, G. Schuler, and M. B. Lutz. 2006. Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity. J. Immunother. 29: 407-415. (Pubitemid 44288953)
41. Baldwin, H. M., T. Ito-Ihara, J. D. Isaacs, and C. M. Hilkens. 2010. Tumour necrosis factor alpha blockade impairs dendritic cell survival and function in rheumatoid arthritis. Ann. Rheum. Dis. 69: 1200-1207.
42. Lepelletier, Y., R. Zollinger, C. Ghirelli, F. Raynaud, R. Hadj-Slimane, A. Cappuccio, O. Hermine, Y. J. Liu, and V. Soumelis. 2010. Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs). Blood 116: 3389-3397.
43. Lombardo, E., A. Alvarez-Barrientos, B. Maroto, L. Boscá, and U. G. Knaus. 2007. TLR4-mediated survival of macrophages is MyD88 dependent and requires TNF-alpha autocrine signalling. J. Immunol. 178: 3731-3739. (Pubitemid 46417641)
44. Wong, B. R., R. Josien, S. Y. Lee, B. Sauter, H. L. Li, R. M. Steinman, and Y. Choi. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186: 2075-2080. (Pubitemid 28013694)
45. Panaretakis, T., L. Hjortsberg, K. P. Tamm, A. C. Björklund, B. Joseph, and D. Grandér. 2008. Interferon alpha induces nucleus-independent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin. Mol. Biol. Cell 19: 41-50. (Pubitemid 351186131)
46. Urban, C., C. Rhême, S. Maerz, B. Berg, R. Pick, R. Nitschke, and C. Borner. 2008. Apoptosis induced by Semliki Forest virus is RNA replication dependent and mediated via Bak. Cell Death Differ. 15: 1396-1407.
47. Ruffolo, S. C., and G. C. Shore. 2003. BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. J. Biol. Chem. 278: 25039-25045. (Pubitemid 37548667)
48. Feoktistova, M., P. Geserick, B. Kellert, D. P. Dimitrova, C. Langlais, M. Hupe, K. Cain, M. MacFarlane, G. Häcker, and M. Leverkus. 2011. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43: 449-463.
49. Tenev, T., K. Bianchi, M. Darding, M. Broemer, C. Langlais, F. Wallberg, A. Zachariou, J. Lopez, M. MacFarlane, K. Cain, and P. Meier. 2011. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 43: 432-448.
50. Ablasser, A., F. Bauernfeind, G. Hartmann, E. Latz, K. A. Fitzgerald, and V. Hornung. 2009. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10: 1065-1072.
51. Chiu, Y. H., J. B. Macmillan, and Z. J. Chen. 2009. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138: 576-591.
52. Yarilina, A., K. H. Park-Min, T. Antoniv, X. Hu, and L. B. Ivashkiv. 2008. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat. Immunol. 9: 378-387. (Pubitemid 351405107)
53. Hu, Y., K. H. Park-Min, A. Yarilina, and L. B. Ivashkiv. 2008. Regulation of STAT pathways and IRF1 during human dendritic cell maturation by TNF-alpha and PGE2. J. Leukoc. Biol. 84: 1353-1360.
54. Palucka, A. K., J. P. Blanck, L. Bennett, V. Pascual, and J. Banchereau. 2005. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc. Natl. Acad. Sci. USA 102: 3372-3377. (Pubitemid 40328052)
55. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13: 816-825.
56. An, H., J. Hou, J. Zhou, W. Zhao, H. Xu, Y. Zheng, Y. Yu, S. Liu, and X. Cao. 2008. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 9: 542-550. (Pubitemid 351560523)
57. Marble, D. J., K. B. Gordon, and B. J. Nickoloff. 2007. Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation. J. Dermatol. Sci. 48: 87-101. (Pubitemid 47381571)
58. Bakleh, M., I. Tleyjeh, E. L. Matteson, D. R. Osmon, and E. F. Berbari. 2005. Infectious complications of tumor necrosis factor-alpha antagonists. Int. J. Dermatol. 44: 443-448. (Pubitemid 40867546)
59. Khan, S., J. D. Greenberg, and N. Bhardwaj. 2009. Dendritic cells as targets for therapy in rheumatoid arthritis. Nat. Rev. Rheumatol. 5: 566-571.